Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7275-7284
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7275
Figure 1
Figure 1 Associations of tumor characteristics and tumor objective response with transarterial chemoembolization. HCC: Hepatocellular carcinoma; OR: Objective responder.
Figure 2
Figure 2 Associations of oval survival of enrolled patients between the objective responder and the non-objective responder groups. OR: Objective responder.
Figure 3
Figure 3 Associations of oval survival of patients among the subgroups with (A) different tumor numbers, (B) different tumor sizes, (C) within or beyond the up-to-7 criteria and (D) different subgroups of BCLC stage B.